Biomet to spin out its dental division named Biomet 3i

Biomet decides to explore options for spinning out its 3i dental devices division, following Abbott's lead and Goldman Sachs' advice to another device maker

In a growing trend among device makers, Biomet Inc.announced that it's exploring strategic options to spin out its 3i dental devices division.
The company is just testing the waters and a split isn't guaranteed, but if completed the move will follow in some notable footsteps.
Abbott (NYSE:ABT) has met with mixed reactions over the last few months after deciding to carve out its research pharmaceuticals business into a separate firm cal...